Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2013 Sep-Oct;45(5):530-1.
doi: 10.4103/0253-7613.117758.

Ceftriaxone-induced hemolysis

Affiliations
Case Reports

Ceftriaxone-induced hemolysis

Vivek S Guleria et al. Indian J Pharmacol. 2013 Sep-Oct.

Abstract

Immune hemolytic anemia is a rare adverse effect of ceftriaxone, a third-generation cephalosporin, which is a commonly used antibiotic. We describe a 60-years-old lady, a case of community-acquired pneumonia, who developed severe hemolysis after the first dose of ceftriaxone. Her hemoglobin dropped from 9.6 g /dl to 5.5 g /dl. However, she improved after discontinuation of the drug and blood transfusion. This report serves as a reminder to medical fraternity that life-threatening hemolysis can rarely follow administration of ceftriaxone.

Keywords: ADRs; ceftriaxone; hemolysis.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: No

Figures

Figure 1
Figure 1
X-ray chest of the patient showing consolidation in right middle zone

References

    1. Garratty G, Postoway N, Schwellenbach J, McMahill PC. A fatal case of ceftriaxone (Rocephin)-induced hemolytic anaemia associated with intravascular immune hemolysis. Transfusion. 1991;31:176–9. - PubMed
    1. Arndt PA, Garratty G. The changing spectrum of drug-induced immune hemolytic anemia. Semin Hematol. 2005;42:137–44. - PubMed
    1. Kelkar PS, Li JT. Cephalosporin allergy. N Engl J Med. 2001;345:804–9. - PubMed
    1. Batchelor FR, Dewdney JM, Weston RD, Wheeler AW. The immunogenicity of cephalosporin derivatives and their cross-reaction with penicillin. Immunology. 1966;10:21–33. - PMC - PubMed
    1. Garratty G. Immune hemolytic anemia associated with drug therapy. Blood Rev. 2010;24:143–50. - PubMed

Publication types